Blue wiss

Blue Wiss (Teramnus labialis): A Comprehensive Reference

1. Identity, Taxonomy, and Nomenclature

Blue Wiss is the English common name for the leguminous plant Teramnus labialis (L.f.) Spreng. Blue wiss in English is the name of a plant defined with Teramnus labialis in various botanical sources. The blue wiss, scientifically known as Teramnus labialis, is a plant species belonging to the Fabaceae family.

The basionym is Glycine labialis L.f., and the plant belongs to the family Fabaceae (alternate name: Leguminosae), subfamily Faboideae, tribe Phaseoleae, subtribe Glycininae. It has the synonym Galactia diversifolia Hoehne, among others.

The plant carries a large number of synonyms and vernacular names across languages and traditions:

• Teramnus labialis Spreng. is commonly known as mashaparni (Sanskrit) and mashavan (Hindi), and is a well-known medicinal plant in the Ayurvedic system of medicine.
• Additional English names include horse vine and rabbit vine. Regional vernacular names span Bengali (mashani), Telugu (karu minumulu, adavi minumulu), Tamil (mashaparuni, kattu alandu), Malayalam (kattulunnu), Marathi (ran-udid), Kannada (adavi uddu), Sanskrit (hayahapuchchi, kalyani, visarini), and Tibetan (mon sran gro u i dab ma).
• The NIH Dietary Supplement Label Database (DSLD) additionally lists the related term Mashparnee on product labels, alongside "Blue wiss" and "Blue wiss extract."

Teramnus labialis (Blue Wiss) is a species of perennial herb in the family Legumes (Fabaceae). The plants are climbers.

2. Botanical Description and Natural Habitat

Blue wiss is an extremely variable perennial, twining or prostrate, trailing vine, some forms stoloniferous, sometimes woody at the base; stems range from 0.3 to 4.0 m long, angular and slender, often covered with adpressed to spreading white to ferruginous hairs, sometimes glabrescent. Leaves are trifoliate, elliptic to ovate, 1 to 8 cm long and 1 to 4 cm broad, densely covered with hairs. Stems grow up to 9 feet long; flowers are small and pink or purplish-white, hairy and ribbed, 1 to 3 mm long.

The native range of the species is the tropics and subtropics; it is a climbing annual or perennial that grows primarily in the seasonally dry tropical biome. It is native to Central America, all of tropical Africa, the Indian Ocean islands, India, and Southeast Asia, and has been introduced in South America (Bolivia, Guyana), Australia (Queensland), and Fiji. T. labialis grows in human-altered environments such as waste areas, abandoned fields, and roadsides.

3. Traditional and Historical Use

3.1 Ayurvedic Medicine (India)

Mashaparni is used in Ayurvedic medicine and is a staple in many Indians' diets, also serving as a component of traditional Indian cuisine. The recognized botanical source of mashaparni is Teramnus labialis Spreng. In the balyamahakashaya gana classification, Charaka Acharya mentions that mashaparni is a common Balya (strength-promoting) medication.

Classical Ayurvedic texts that reference mashaparni include Sushruta (in the Kakolyadi and Vidarigandhadi groups), Vagbhata (in the Shukrajanana and Vidarigandhadi groups), Kaiyadeva Nighantu (Oshadhi Varga), and the Bhavaprakasha, Raja Nighantu, and Dhanvantari Nighantu (in the Guduchyadi Varga).

Ayurvedic characterization assigns the following qualities to the plant: its taste (rasa) is sweet (madhura) and bitter (tikta); its post-digestive quality (vipaka) is sweet; its potency (veerya) is cooling (sheeta); it balances Vata and Pitta doshas and increases Kapha dosha; the parts used are the root and the whole plant; the traditionally prescribed dosage is decoction 50–100 ml or powder 3–6 g.

Classic Ayurvedic indications attributed to mashaparni include: improving sperm quantity and quality (shukrala), aphrodisiac action (vrushya), usefulness in diarrhea and IBS (sangrahi), blood disorders and bleeding conditions (asrajit), nutritional support (pushtivardhini), burning sensation conditions (daha), fever (jwara), bleeding disorders including heavy menstrual periods and nosebleeds (raktapitta), and swelling or inflammation (shotha).

In the Ayurvedic system of medicine, the root powder is used as an important ingredient in Chyawanprash and is also considered helpful in general debility, malnutrition, and fatigue.

The Ayurvedic Pharmacopoeia of India recommends the plant in spermatorrhoea. Traditionally, the fruit is described as aphrodisiac, stomachic, nervine tonic, astringent to the bowels, antipyretic, and galactagogue. It has also been used in inflammation, biliousness, blood diseases, gout, fevers, bronchitis, thirst, burning sensation, paralysis, rheumatism, affections of the nervous system, haemoptysis, tuberculosis, and catarrh.

3.2 Siddha Medicine (South India)

In the Siddha system of medicine, the plant is used in treatment of sexual debility.

3.3 Tribal and Folk Uses

Seeds of Teramnus labialis have been used as food by Malayali tribals in the Kollihills of Salem District, Tamil Nadu in South India. The fruits of the plant have been used as a galactagogue by various traditional practitioners and tribal peoples of India.

4. Common Forms and Preparations

Based on source-verified reports, T. labialis is prepared and used in the following forms:

• Decoction — aqueous preparation from the whole plant or root, used orally in Ayurveda. The classically reported dose is 50–100 ml of decoction.
• Powder (churna) — dried and ground whole plant or root. The classical powder dose is 3–6 g.
• Methanolic extract — used in laboratory and pharmacological research to isolate active constituents and evaluate biological activity.
• Aqueous alcoholic extract — used in research on antihyperglycemic and anti-inflammatory properties. In vivo bioassay-guided fractionation of the aqueous alcohol extract of the aerial parts of T. labialis, using C57BL/Ks-db/db mice as a model for type 2 diabetes, yielded an active fraction containing a mixture of coumarins, of which the major constituent was identified as fraxidin.
• Whole plant extract — researched for its therapeutic properties, particularly immunomodulatory effects, used in the form of a whole plant extract.
• Dietary supplement extract — listed in the NIH Dietary Supplement Label Database (DSLD) under the category "Botanical," with common label terms including "Blue wiss," "Blue wiss extract," and "Mashparnee."

5. Key Chemical Constituents and Active Compounds

5.1 Overview of Secondary Metabolite Profile

T. labialis has long been utilized in Ayurveda and traditional medicine and has a variety of pharmacological properties. Its extensive secondary metabolite profile, which includes terpenoids, alkaloids, flavonoids, and phenolic chemicals, is largely responsible for these medicinal benefits.

5.2 Isolated Bioactive Compounds

Fraxidin (a coumarin): Bioassay-guided fractionation based on anti-hyperglycaemic activity of an aqueous alcoholic extract of T. labialis yielded fraxidin as the major active constituent. The major bioactive phytoconstituents identified in the plant are fraxidin and galactomannan.

Galactomannan: Phytochemical investigation on the seeds of T. labialis yielded a water-soluble galactomannan.

Vitexin, Bergenin, and Daidzin: Bioassay-guided fractionation based on anti-inflammatory activity of the methanolic extractives of Teramnus labialis led to the isolation and characterization of vitexin, bergenin, daidzin, and 3-O-methyl-D-chiro-inositol as active constituents. This was the first reported occurrence of vitexin, bergenin, daidzin, and 3-O-methyl-D-chiro-inositol in T. labialis.

Flavonol glycoside: A novel bioactive flavonol glycoside (molecular formula C₂₆H₂₈O₁₇) has been isolated from T. labialis.

Nutritional constituents: Crude protein, crude fat, ash, and nitrogen-free extracts constituted 22.86%, 6.10%, 4.62%, and 58.15% respectively of the seed weight. The caloric value of 100 g dry matter of seed material was 378.94 kcal. The essential amino acids lysine, leucine + isoleucine, arginine, valine, and histidine were present in relatively large quantities. The unsaturated fatty acids constituted more than 60% of the crude fat. Concentrations of minerals such as potassium, magnesium, calcium, and phosphorus were high.

5.3 Mechanisms of Action

5-Lipoxygenase inhibition (anti-inflammatory pathway): Vitexin exhibited a dose-dependent inhibitory activity on 5-lipoxygenase enzyme. The isolation and characterization of vitexin, bergenin, and daidzin — known anti-inflammatory compounds — from the methanolic extractives of T. labialis substantiates the traditional use of T. labialis in treating rheumatism. Vitexin may exhibit anti-inflammatory activity by inhibiting the 5-lipoxygenase pathway.

Antioxidant activity: The isolated constituents were screened for antioxidant activity by the nitroblue tetrazolium (NBT) riboflavin photoreduction method; vitexin exhibited moderate antioxidant activity.

Bergenin — multi-target compound: Bergenin has aroused widespread interest because of its several pharmacological activities, mainly antioxidant and anti-inflammatory. In addition, bergenin has shown potential antimalarial, antileishmanial, trypanocidal, antiviral, antibacterial, antifungal, antinociceptive, antiarthritic, antiulcerogenic, antidiabetic/antiobesity, antiarrhythmic, anticancer, hepatoprotective, neuroprotective, and cardioprotective activities.

6. Scientific Evidence by Area of Use

Important context: Despite its historical importance, there are very few thorough phytochemical and pharmacological analyses available for T. labialis. The current body of research consists largely of preclinical (animal and in vitro) studies; no large-scale randomized controlled human clinical trials have been identified in indexed literature. All clinical claims should be interpreted accordingly.

6.1 Anti-Inflammatory Activity

Evidence type: In vitro and preclinical bioassay.

T. labialis has a variety of pharmacological properties, including antibacterial, hepatoprotective, antioxidant, and anti-inflammatory actions. The anti-inflammatory research published in the Indian Journal of Pharmaceutical Sciences (Sridhar et al., 2006) used bioassay-guided fractionation of methanolic extracts of aerial parts collected from the Tirumala Hills of Andhra Pradesh. This fractionation led to the isolation and characterization of vitexin, bergenin, daidzin, and 3-O-methyl-D-chiro-inositol as active anti-inflammatory constituents, with vitexin exhibiting dose-dependent inhibitory activity on the 5-lipoxygenase enzyme. This evidence is laboratory-based; no human clinical trials on the anti-inflammatory effects of T. labialis have been published in peer-reviewed literature at this time.

6.2 Antihyperglycemic / Anti-Diabetic Activity

Evidence type: In vivo animal study.

In vivo bioassay-guided fractionation of the aqueous alcohol extract of the aerial parts of Teramnus labialis (Roxb.) Benth. (Fabaceae), using C57BL/Ks-db/db mice as a model for type 2 diabetes, yielded an active fraction containing a mixture of coumarins; the major coumarin present in the active fraction was identified as fraxidin. This PubMed-indexed study (Phytomedicine, 2000) was conducted by researchers at Shaman Pharmaceuticals.

A comparative study published in the Asian Pacific Journal of Health Sciences (2022) evaluated T. labialis alongside Xanthium strumarium for anti-diabetic properties. Methyl extracts of T. labialis were collected, dried, and powdered; healthy male Wistar albino rats with streptozotocin-nicotinamide and alloxan-induced diabetes were studied on days 1, 7, 14, 21, and 28 for serum glucose, total cholesterol, triglycerides, HDL, and LDL levels, compared against the standard drug glibenclamide. When extracts were administered at low dose in combination, they exhibited a valuable synergistic activity on mean blood glucose levels. These results are from animal models only and have not been replicated in human trials.

6.3 Antioxidant Activity

Evidence type: In vitro assay and preclinical.

Seeds of Teramnus labialis are a rich source of bioactive chemicals with potential to prevent and treat illness. Seeds were analyzed for protein, starch, reducing sugar, total sugar, antioxidant activity, and vitamin content. Protein value was 26.62 mg/g, 0.98 mg/g total sugar, 0.373 mg/g starch, and 0.1 mg/g reducing sugar. The antioxidant assay was performed for estimation of reducing power using DPPH, ABTS, CUPRAC, and PMA methods. Earlier scientific investigation suggested that the whole plant as well as roots possess antioxidant, anti-inflammatory, antihyperglycemic, and hypolipidemic activity.

6.4 Galactagogue (Lactation-Promoting) Activity

Evidence type: In vivo animal study (PMC-indexed).

A study published in a peer-reviewed journal and indexed in PMC (PubMed Central) evaluated the lactogenic activity of a methanolic extract of T. labialis fruit in nursing rats. According to the findings of this experimental investigation, the domperidone group and the methanolic extract of T. labialis fruit at doses of 200, 400, and 600 mg/kg produced 22%, 53%, 75%, and 58% increases in milk production respectively compared to control. The pups' body weight doubled on the fifteenth day of nursing, and the methanolic extract group experienced a considerably higher rate of weight gain than the standard and control groups. The fruits of this plant have been used as a galactagogue by various traditional practitioners and tribal peoples of India. These findings are preclinical (rat model) only; no human evidence exists.

6.5 Hepatoprotective Activity

Evidence type: Preclinical (cited in review literature).

The entire plant, including the roots, may have antioxidant, anti-inflammatory, antihyperglycemic, and hypolipidemic properties, according to earlier studies. T. labialis is reported to possess hepatoprotective actions. The evidence for hepatoprotection is referenced in review literature but originates from preclinical studies; human clinical data are absent from indexed sources.

6.6 Immunomodulatory Activity

Evidence type: Laboratory / preclinical.

Immunomodulatory activity of mashaparni (Teramnus labialis Spreng.) was studied and published in the Journal of Ayurveda and Integrated Medical Sciences (volume 4, issue 06, 2019). This extract has been researched for its therapeutic properties, particularly its immunomodulatory effects, using the form of a whole plant extract. Human clinical trials on this property have not been identified in indexed databases.

6.7 Antimicrobial / Antibacterial Activity

Evidence type: Preclinical in vitro.

Teramnus labialis is a rich source of compounds that may be used to cure and prevent many diseases; diterpenoids, flavonoids, and iridoids are examples of compounds from the plant that have a variety of properties including antibacterial, anti-inflammatory, and antioxidant properties. No human clinical studies on antimicrobial effects have been identified.

7. Body Systems and Health Areas Associated with Blue Wiss

Based on traditional records and preclinical research, the following body systems and health domains have been associated with T. labialis in the available literature:

• Musculoskeletal / Inflammatory system: It has been reported to be useful in treating rheumatism.
• Nervous system: It has been reported to be useful in treating nerve disorders and paralysis.
• Endocrine / Metabolic system (glucose regulation): Preclinical antihyperglycemic effects identified via fraxidin.
• Reproductive system: The Ayurvedic Pharmacopoeia of India recommends the plant in spermatorrhoea. Traditional use includes aphrodisiac and galactagogue applications.
• Hepatic (liver) system: Hepatoprotective activity noted in preclinical review literature.
• Immune system: Immunomodulatory activity studied in preclinical settings.
• Gastrointestinal system: It is used in traditional Ayurvedic medicine to support digestion and relieve digestive discomfort.
• Urinary system: Teramnus labialis may act as a diuretic, promoting the production of urine, which can be helpful in conditions such as urinary tract infections or to support kidney health.
• Respiratory system: Traditional reports include use in tuberculosis, bronchitis, and catarrh.
• Hematological system: Traditional Ayurvedic use includes blood disorders and bleeding conditions.

8. Dosage Forms and Dosages Reported in Sources

The following dosages appear specifically in identified sources and are reported here as documented, not as recommendations:

• Ayurvedic classical dosage: Decoction 50–100 ml; powder 3–6 g (whole plant or root).
• Galactagogue animal study: Methanolic extract of fruit administered at 200, 400, and 600 mg/kg body weight in nursing rats, producing 53%, 75%, and 58% increases in milk production respectively compared to control.
• Anti-inflammatory / antihyperglycemic research: Methanolic and aqueous-alcoholic extracts of aerial parts; specific mg/kg doses for these studies are not fully detailed in the available abstracts.

No human clinical trial dosages for T. labialis extract have been identified in indexed peer-reviewed literature. The NIH Dietary Supplement Label Database records the ingredient but notes scientific resources as "N/A" for Blue Wiss extract, reflecting the absence of established human dosage guidelines in regulatory or institutional databases.

9. Safety Considerations

9.1 Antinutritional Factors in Seeds

Antinutritional factors such as total free phenols, tannins, L-DOPA, hydrogen cyanide, and phytic acid were present in minute quantities in T. labialis seeds. These antinutritional factors are potentially eliminated using the conventional method of soaking the seeds in water, boiling with water, and decanting prior to consumption.

The presence of L-DOPA (levodopa) as an antinutritional factor in the seeds is notable from a pharmacological standpoint; L-DOPA is a precursor of dopamine and the primary drug used in Parkinson's disease management, and its interactions with monoamine oxidase inhibitors (MAOIs) and other dopaminergic agents are well-established. The seed levels in T. labialis are reported as minute and reduced by standard food processing, but this warrants awareness in medicinal preparations using unprocessed seed material.

9.2 Traditional Food Safety Context

Seeds of T. labialis have been used as food by Malayali tribals in the Kollihills of Salem District, Tamil Nadu in South India, suggesting a longstanding history of consumption in that population without documented acute toxicity when traditionally prepared.

9.3 Limitations of the Safety Evidence Base

Despite its historical importance, there are very few thorough phytochemical and pharmacological analyses available for T. labialis. No formal human toxicological studies, no systematic reviews of adverse events, and no established safety pharmacology data from clinical trials have been identified in peer-reviewed databases. The NIH DSLD entry for Blue Wiss extract lists no scientific safety resources. The body of preclinical animal work has not reported significant toxicity signals in the studies identified, but this does not constitute a formal safety clearance.

9.4 Pregnancy and Lactation

Traditional Ayurvedic use of the plant as a galactagogue (milk-promoting agent) in nursing mothers is documented, and an animal study demonstrated milk-increasing effects at specific doses. However, the presence of L-DOPA and phytic acid, even at minute levels, means that raw or unprocessed seed preparations have not been formally evaluated for safety in human pregnancy or lactation in clinical settings.

9.5 Drug Interactions — Potential Considerations Based on Phytochemistry

The isolated constituent daidzin is an isoflavone glucoside with estrogenic activity; its presence in the plant raises theoretical considerations around use alongside hormonal therapies or in estrogen-sensitive conditions, though no human interaction studies specific to T. labialis have been published. The antihyperglycemic effects identified in animal models suggest a theoretical potential for additive blood glucose-lowering effects if taken concurrently with antidiabetic medications — a consideration documented for many botanical hypoglycemics — but again, no human data confirm this for T. labialis specifically.

10. Current State of Research and Evidence Gaps

The lesser-known leguminous plant Teramnus labialis has attracted a lot of interest because of its various therapeutic uses and bioactive ingredients. T. labialis, which has long been utilized in Ayurveda and traditional medicine, has a variety of pharmacological properties including antibacterial, hepatoprotective, antioxidant, and anti-inflammatory actions. Studies on other Teramnus species and plants in the Fabaceae family can shed light on possible secondary metabolites, even if T. labialis's secondary metabolites appear to have received relatively little attention.

The key evidence gaps are:

• No randomized controlled human clinical trials have been identified for any claimed indication.
• No systematic reviews or meta-analyses are available on PubMed/Cochrane.
• No official monographs have been published by the WHO, ESCOP, Commission E, or EFSA specifically for Teramnus labialis as a medicinal herb or dietary supplement ingredient.
• Pharmacokinetic data (absorption, distribution, metabolism, excretion in humans) are absent from indexed literature.
• Standardization of extracts (consistent quantification of fraxidin, vitexin, bergenin, or other key markers) has not been reported in available sources.

References

• NIH Office of Dietary Supplements — Dietary Supplement Label Database: Blue Wiss Extract
• Encyclopedia of Life — Teramnus labialis (Blue Wiss)
• Wisdom Lib — Blue Wiss: Botanical Definition
• Plants of the World Online (Kew Science) — Teramnus labialis (L.f.) Spreng.
• Tropical Forages — Teramnus labialis
• Wiktrop — Teramnus labialis Species Profile
• Leon Levy Native Plant Preserve — Teramnus labialis
• Sridhar C, Krishnaraju AV, Subbaraju GV. "Antiinflammatory Constituents of Teramnus labialis." Indian Journal of Pharmaceutical Sciences 68(1):111–114, 2006.
• Fort DM et al. "Antihyperglycemic Activity of Teramnus labialis (Fabaceae)." Phytomedicine. PubMed PMID: 10715850.
• Lactogenic Activity of Teramnus labialis Fruit with Special Reference to Serum Prolactin and Cortisol Levels in Nursing Rats. PMC5155476.
• Comprehensive Review on Pharmacological Activity and Secondary Metabolites of Teramnus labialis L. — IJSRT Journal.
• Nutritional Profiling and Antioxidant Activity of Teramnus labialis (L.F) Spreng Seeds — IJSRT Journal.
• Monica CL, Vishnuvardhan Z. "Comparative Study of Teramnus labialis and Xanthium strumarium for Anti-Diabetic Property." Asian Pacific Journal of Health Sciences 9(1):58–61, 2022.
• ResearchGate — Antiinflammatory Constituents of Teramnus labialis (PDF)
• Viswanathan MB, Thangadurai D, Tamil Vendan K, Ramesh N. "Chemical Analysis and Nutritional Assessment of Teramnus labialis (L.) Spreng. (Fabaceae)." Plant Foods for Human Nutrition 54:345–352, 1999. Springer Nature.
• Easy Ayurveda — Mashaparni (Teramnus labialis): Uses, Dose, Research
• Pradeep S, Shiva Manjunath MP. "Immunomodulatory Activity of Mashaparni — Teramnus labialis Spreng." Journal of Ayurveda and Integrated Medical Sciences 4(06):13–18, 2019.